The purpose of this study is to study the clinical profile in endometrial Hyperplasia. This observational study was conducted at Amrita Institute of Medical Sciences, Kochi, Kerala, India, a tertiary care referral center, over a duration of two years from July 2019‐2021. Ethical approval was obtained from the institutional ethical committee. The study included 68 women diagnosed with endometrial hyperplasia, all of whom reported to the gynecological outpatient department (OPD) for evaluation of abnormal uterine bleeding. In this study, the mean age of patients with endometrial hyperplasia was 49 years, with 63.7% of cases showing hyperplasia with atypia. Among the study population, 88% were multiparous and the most common presenting complaint was heavy menstrual bleeding, observed in 50% of patients. Diabetes mellitus and hypertension were prevalent comorbidities, affecting 64% of the participants. Ultrasound findings indicated a mean endometrial thickness of 12 mm for hyperplasia with atypia, with adenomyosis and fibroids present in 30% of cases. This study reveals that endometrial hyperplasia predominantly affects women around the age of 49, with abnormal uterine bleeding as the most common presenting symptom. Diabetes mellitus and hypertension are key risk factors, while ultrasound findings show no significant difference in endometrial thickness between hyperplasia types. The high prevalence of adenomyosis and fibroids suggests a need for careful clinical evaluation in these patients.
Pragalya Loganathan, Vinita Murali, Sheena P. Kochumon and K. Radhamany. Clinical Profile and Characteristics of Patients with Endometrial Hyperplasia.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.10.176.180
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.10.176.180